The estimated Net Worth of Paul B. K. Kusserow is at least $54.1 Million dollars as of 1 February 2023. Mr. Kusserow owns over 5,777 units of Amedisys stock worth over $35,836,985 and over the last 16 years he sold AMED stock worth over $5,424,014. In addition, he makes $12,835,500 as Chairman of the Board, President, and Chief Executive Officer at Amedisys.
Paul has made over 11 trades of the Amedisys stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 5,777 units of AMED stock worth $558,751 on 1 February 2023.
The largest trade he's ever made was exercising 500,000 units of Amedisys stock on 10 August 2020 worth over $13,360,000. On average, Paul trades about 19,767 units every 97 days since 2009. As of 1 February 2023 he still owns at least 370,523 units of Amedisys stock.
You can see the complete history of Mr. Kusserow stock trades at the bottom of the page.
Paul B. Kusserow serves as Chairman of the Board, President, Chief Executive Officer of the Company. He is our President and Chief Executive Officer (since December 2014) and Chairman of the Board (since October 2019) and has been a member of our Board of Directors since joining our Company in December 2014. Previously, he was Vice Chairman and President of Alignment Healthcare, Inc., an integrated clinical care and health plan company, from June 2014 until December 2014. From December 2013 until June 2014, Mr. Kusserow served as a consultant for Boston Consulting Group (BCG), where he advised Amedisys on corporate strategy. Before that, he served as Senior Vice President, Chief Strategy, Innovations and Corporate Development Officer of Humana, Inc., a healthcare services and benefits company, from February 2009 through December 2013. Prior to joining Humana, Inc., he was Managing Director and Chief Investment Officer of the Ziegler HealthVest Fund, a venture capital fund focused on early to mid-stage investments in healthcare services, healthcare technology and wellness; a co-founder and Managing Director of San Ysidro Capital Partners, L.L.C., an investment advisory and management firm specializing in healthcare services and technology; and Managing Partner of Roaring Mountain, L.L.C., a strategy consulting and investment management firm with large clients in healthcare services and technology. Mr. Kusserow began his healthcare career with Tenet Healthcare Corporation, one of the nation’s largest investor-owned healthcare service companies, where he spent seven years, the last four as Senior Vice President, Strategy and Tenet Ventures. He began his career as a management consultant at McKinsey & Company. He has served on many corporate and advisory boards, and currently serves on the Boards of Directors of Oak Street Health, Picwell, Inc., and Matrix Medical Network. He previously served on the Board of Directors of Connecture, Inc., New Century Health, Inc., AxelaCare Health Solutions, Inc.
As the Chairman of the Board, President, and Chief Executive Officer of Amedisys, the total compensation of Paul Kusserow at Amedisys is $12,835,500. There are no executives at Amedisys getting paid more.
Paul Kusserow is 58, he's been the Chairman of the Board, President, and Chief Executive Officer of Amedisys since 2019. There are 6 older and 11 younger executives at Amedisys. The oldest executive at Amedisys Inc. is Molly Coye, 72, who is the Independent Director.
Paul's mailing address filed with the SEC is 3854 AMERICAN WAY, SUITE A, , BATON ROUGE, LA, 70816.
Over the last 27 years, insiders at Amedisys have traded over $269,564,877 worth of Amedisys stock and bought 2,690,968 units worth $38,198,016 . The most active insiders traders include Asset Management Llc Kohlbe..., Tide Capital, Llc North Tid..., and David Nierenberg. On average, Amedisys executives and independent directors trade stock every 29 days with the average trade being worth of $2,494,602. The most recent stock trade was executed by Richard M Ashworth on 26 December 2023, trading 11,237 units of AMED stock currently worth $896,937.
amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i
Amedisys executives and other stock owners filed with the SEC include: